(KRYS) – Hot Corp. News
-
Krystal Biotech (KRYS) Receives FDA Approval for VYJUVEK
-
Krystal Biotech (KRYS) Announces Positive Topline Results from GEM-3 Pivotal Trial of VYJUVEK in Patients with Dystrophic Epidermolysis Bullosa
-
Back to KRYS Stock Lookup